TY - JOUR
T1 - Differential effect of insulin like growth factor-I on constriction of human uterine and placental arteries
AU - Corcoran, Jemma J.
AU - Charnock, Jayne C.
AU - Martin, Julie
AU - Taggart, Michael J.
AU - Westwood, Melissa
PY - 2012/11/1
Y1 - 2012/11/1
N2 - Context: Discrete regulation of the uterine and placental vasculatures is an important feature of uteroplacental perfusion and pregnancy success because appropriate maternal/fetal exchange of nutrients and gases is crucial for normal fetal growth. Placental vasculature lacks autonomic innervation so tone is controlled by locally derived vasoactive factors. IGF-I, which is produced by the placenta, is critical for normal fetal growth and studies of animal vascular systems have shown that IGF-I regulates vasomotor tone. Objective: The objective of the study was to determine whether IGF-I directly alters human placental and myometrial arterial tone in vitro. Participants: Women with uncomplicated pregnancy delivering a singleton infant at term participated in the study. Setting: The study was conducted at university hospital laboratories. Main Outcome Measure(s): Comparison of arterial tension measured before and after exposure to IGF-I. Design: Placental and myometrial arteries were mounted on a wire myograph, exposed to the constrictor U46619 (10-10 to 10-5 M), returned to baseline tension, and then incubated with IGF-I (0-500 ng/ml) for various time points before performing a second dose-response curve to U46619. IGF-I receptor protein expression was assessed. Results: IGF-I did not acutely alter the response of placental arteries to U46619. Exposure of myometrial arteries to IGF-I caused a rightward shift of U46619 dose-response curves (P < 0.05); EC50 data were significantly increased at 30 (15.5 ± 2.8 vs. 133 ± 44 nM, before and after IGF treatment, respectively) and 60 min (10.9 ± 1.9 vs. 146 ± 47 nM). Placental and myometrial arteries had a similar IGF-I receptor expression profile. Conclusions: IGF-I acutely modulates the vasomotor tone of human myometrial, but not placental, arteries, suggesting that IGF-I regulates the delivery of maternal blood to the placenta.
AB - Context: Discrete regulation of the uterine and placental vasculatures is an important feature of uteroplacental perfusion and pregnancy success because appropriate maternal/fetal exchange of nutrients and gases is crucial for normal fetal growth. Placental vasculature lacks autonomic innervation so tone is controlled by locally derived vasoactive factors. IGF-I, which is produced by the placenta, is critical for normal fetal growth and studies of animal vascular systems have shown that IGF-I regulates vasomotor tone. Objective: The objective of the study was to determine whether IGF-I directly alters human placental and myometrial arterial tone in vitro. Participants: Women with uncomplicated pregnancy delivering a singleton infant at term participated in the study. Setting: The study was conducted at university hospital laboratories. Main Outcome Measure(s): Comparison of arterial tension measured before and after exposure to IGF-I. Design: Placental and myometrial arteries were mounted on a wire myograph, exposed to the constrictor U46619 (10-10 to 10-5 M), returned to baseline tension, and then incubated with IGF-I (0-500 ng/ml) for various time points before performing a second dose-response curve to U46619. IGF-I receptor protein expression was assessed. Results: IGF-I did not acutely alter the response of placental arteries to U46619. Exposure of myometrial arteries to IGF-I caused a rightward shift of U46619 dose-response curves (P < 0.05); EC50 data were significantly increased at 30 (15.5 ± 2.8 vs. 133 ± 44 nM, before and after IGF treatment, respectively) and 60 min (10.9 ± 1.9 vs. 146 ± 47 nM). Placental and myometrial arteries had a similar IGF-I receptor expression profile. Conclusions: IGF-I acutely modulates the vasomotor tone of human myometrial, but not placental, arteries, suggesting that IGF-I regulates the delivery of maternal blood to the placenta.
UR - http://www.scopus.com/inward/record.url?scp=84868616913&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868616913&partnerID=8YFLogxK
U2 - 10.1210/jc.2012-1679
DO - 10.1210/jc.2012-1679
M3 - Article (journal)
C2 - 22948758
AN - SCOPUS:84868616913
SN - 0021-972X
VL - 97
SP - E2098-E2104
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 11
ER -